About
Professor Ralph F. Hall is a professor of practice at the University of Minnesota Law School and teachers MILI 6421 Healthcare Law: Strategic and Business Implications. He concentrates his teaching, research and writing in the area of FDA regulation and health care. He is also a principal with Leavitt Partners, a health care policy and consulting firm. At Leavitt Partners he works with coalitions and clients focused on improving FDA and health care regulation and advancing value based health care. He also serves as CEO of MR3 Medical LLC, a start-up medical device company. He is a frequent speaker on FDA regulatory issues and compliance matters and has testified a number of times before Congressional committees.
Prior to his association with the University of Minnesota Law School, Professor Hall served in various capacities with Guidant Corporation including Senior Vice President and Deputy General Counsel—Litigation and Compliance and General Counsel of the Cardiac Rhythm Management group. During this time, Professor Hall also served as Special Counsel to the Guidant Board of Directors Compliance Committee and as Counsel to the Guidant Chief Compliance Officer. Prior to joining Guidant, he was with Eli Lilly, including serving as the head of Lilly’s worldwide environmental law group. He has also served in an Of Counsel role with the law firm of Faegre Baker Daniels.
Professor Hall received his B.A. magna cum laude from Indiana University in 1974 and his J.D. cum laude from the University of Michigan where he was a Weymouth Kirkland Scholar. Professor Hall’s interests include FDA regulation, corporate compliance and governance, negotiations and the interface between corporate practice and the academic world.